Fosmanogepix

DB15183InvestigationalSmall molecule

Fosmanogepix is under investigation in clinical trial NCT03604705 (An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia).

Chemical structure of Fosmanogepix
Formula / weight
C22H21N4O6P · 468.406 g/mol (avg)
Code names
APX-001

Resolves to

Compound
UNII1XQ871489PCAS2091769-17-2ChEMBLCHEMBL4297591
Structure
InChIKeyJQONJQKKVAHONF-UHFFFAOYSA-NSMILESNC1=C(C=CC=[N+]1COP(O)([O-])=O)C1=CC(CC2=CC=C(COC3=NC=CC=C3)C=C2)=NO1

What you can answer from here — as of April 23, 2025

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Fosmanogepix, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In